GEM: Building a Closed-Loop New Energy Circular Economy and Embarking on a New Chapter of Global Growth with its Listing in Hong Kong

HONG KONG, Sep 30, 2025 - (ACN Newswire via SeaPRwire.com) – Driven by the “Dual Carbon” strategy, the new energy industry is experiencing rapid growth, with demand for critical new energy metal such as lithium, nickel, and cobalt continuing to surge. However, the exploitation of upstream mineral resource is constrained by environmental concerns, rising costs, and international geopolitical risks, leading to emerging resource bottlenecks. At the same time, as the warranty periods for power batteries gradually expire, a wave of retired batteries is accelerating. Waste-battery recycling, critical metal regeneration, and battery material remanufacturing are becoming emerging growth drivers across the industry chain.Having cultivated expertise in this field for many years, GEM Co., Ltd. (“GEM”, 002340.SZ) has been consistently expanding its presence in the circular economy. The Company has established an integrated circular economy operation model that covers three key businesses: critical metal resources, lithium-ion battery and end-of-life vehicle recycling, and new energy materials. In several niche material markets, GEM ranks among the global leaders. Recently, the Company submitted a listing application to the Hong Kong Stock Exchange, aiming to achieve dual listing on both A and H shares.Three Key Businesses Form a Closed-loop Circular System, with Technology Enabling “Waste-to-Value”GEM’s uniqueness lies in its full-chain closed-loop model built around the concept of a circular economy: “resource recovery — material remanufacturing — product application”. By organically integrating three key business modules of critical metal resources recycling, power batteries and end-of-life vehicles recycling, and new energy materials, the Company not only achieves efficient resource utilization but also significantly enhances the added value of products.In terms of resource recovery, GEM leverages a global recycling network to carry out large-scale collection and dismantling of various resources, including waste-battery, end-of-life vehicles, and electronic waste. To date, the Company has formed partnerships with over 1,000 automotive companies and battery manufacturers worldwide, establishing a stable raw material recycling network and product sales channels. This not only ensures a steady supply of “Urban Mining” resources such as retired batteries and end-of-life vehicles, but also opens up vast market opportunities for new energy materials, positioning the Company as a central hub in the industry chain with risk-resilience significantly stronger than its peers.In terms of material regeneration, GEM utilizes advanced processes to transform recycled resources into high-purity, high value-added intermediate products and new energy materials. As one of the early adopters of hydrometallurgical technology in the industry, the Company utilized this advanced technology to smelt limonite nickel ore, which could hardly be smelted through traditional pyrometallurgy. The process also enables the efficient smelting of other metal resources associated with laterite nickel ore, enhancing overall economic value while achieving recovery rates of up to 99% for nickel, cobalt, and tungsten. In terms of lithium-ion battery and end-of-life vehicle recycling, GEM has established a dual-track processing model of “cascade utilization + material regeneration”, achieving a recovery rate of 96.5% for lithium metal, significantly exceeding the industry average of 90%. More importantly, through technological innovation, GEM further processes recycled resources into high value-added critical new energy materials such as ternary precursors, cathode materials, and cobalt tetroxide, supplying to global battery manufacturers and vehicle OEMs. This truly achieves a complete closed loop process from recycling to application.GEM’s three core businesses are mutually supportive and closely interconnected. The recycling of critical metals and power batteries jointly provides a stable metal supply for the production of new energy materials. Meanwhile, the materials business extends downstream, supplying to battery manufacturers and achieving value-added transformation. This turns green recycling into a profitable and sustainable industrial chain, creating a competitive barrier that is difficult for industry peers to replicate.Leading in Multiple Segments and Seizing the Future Opportunities with a Global ExpansionLeveraging its technological barriers and industrial synergy advantages, GEM has established a globally leading position across multiple segments, emerging as a frontrunner in the new energy materials and resource recycling sector. According to Frost & Sullivan, GEM ranked first in China in the recycling of nickel, cobalt, tungsten resources in terms of recycling volume in 2024, as well as retired lithium-ion battery recycling volume from third parties. In the field of new energy materials, GEM was the second largest supplier of ternary precursors globally in terms of shipment volume in 2024, capturing a market share of 19.7%. At the same time, with a market share of 37.4%, it became the world’s largest supplier of high-nickel ternary precursors, with the shipment volume of its 8-series and 9-series high-nickel ternary precursor materials ranking first globally. In the cobalt tetroxide sector, the Company ranked second worldwide with a market share of 20.2%.Looking ahead, GEM is embracing multiple market opportunities. The expansion of new energy applications is driving sustained growth in demand for critical new energy metals. According to Frost & Sullivan, from 2024 to 2030, nickel demand in China is expected to rise from 335.5 thousand tons in 2024 to 1,233.7 thousand tons in 2030, with the proportion of recycled nickel increasing from 17.2% to 31.1%; Demand for cobalt and tungsten in China will also grow in tandem, while the proportion of recycled cobalt and recycled tungsten will further increase. In addition, under the wave of retired power batteries, it is expected that by 2030, around 15% of the nickel, cobalt, and lithium required for new power batteries will come from recycling.In the field of new energy materials, driven by emerging sectors such as EVs, 3C electronics, low-altitude aircrafts, and humanoid robots, market demand is expected to grow rapidly. In terms of shipment volume, from 2024 to 2030, the CAGR of lithium-ion battery cathode materials is expected to reach 24.2% while that of ternary precursors is projected at 21.6%. Among them, the penetration rate of high-nickel ternary precursors is expected to rise from 35.2% to 70.0%, and the shipment volume of cobalt tetroxide is expected to record a CAGR of 12.7%.Confronting opportunities, GEM has formulated a clear development strategy. On the technology front, it plans to establish overseas R&D centers, increase R&D investment, and deepen the deployment of cutting-edge technologies in the field of new energy materials. On the capacity front, it will expand and upgrade existing production capacity, advance the expansion of its Indonesian base, and strengthen the “nickel resources — precursors — cathode materials” integrated nickel industrial chain. On the globalization front, it intends to set up marketing centers in Japan, South Korea, and Indonesia, enhance customer collaboration, and further expand its global business footprint.GEM’s proposed listing in Hong Kong will provide GEM with broader access to capital and international markets, injecting stronger momentum into its dual growth engines of circular economy and new energy materials. Backed by robust technological barriers, a mature closed-loop model, and an expanding global footprint, the Company is well-positioned to maintain its leading edge in the circular economy sector and unlock greater growth flexibility. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
金葉國際集團有限公司宣佈於香港交易所GEM上市計劃 ACN Newswire

金葉國際集團有限公司宣佈於香港交易所GEM上市計劃

投資亮點:- 金葉國際是香港機電工程行業老牌承建商,擁有近20年行業經驗,專注於暖氣、通風及冷氣調節系統工程,佔集團的收入超過90%。- 在過去兩個年度,集團分別完成超過1,000個不同規模的項目。於截至2025年7月31日,集團手上擁有187個項目,未完成訂單價值約為62.8百萬港元。此外,集團亦已獲得一項目續期,項目由2025年9月起為期三年,合約金額預計不少於50百萬港元。- 2025年3月31日止年度,比上一財年,集團的收入增加約25.6%至約154.5百萬港元,年內利潤亦增加約35.7%至約14.1百萬港元。2025年3月31日止年度,毛利率及淨利潤率分別為約20.4%及9.1%。- 集團作為主承建商與香港許多大型物業管理公司建立業務關係,行業地位穩固。- 管理團隊在機電工程行業經驗豐富,執行董事擁有20至30年以上行業經驗。- 集團開發「GL ERP」雲端系統推動高效項目管理。- 集團實施嚴格的運作體系,已獲得ISO 9001:2015質量管理系統、ISO 14001:2015環境管理系統及ISO 45001:2018職業健康與安全管理體系的全面認證。香港,2025年9月30日 - (亞太商訊 via SeaPRwire.com) – 香港老牌機電工程承建商金葉國際集團有限公司(「金葉國際」或「公司」,連同其附屬公司簡稱「集團」)今日宣佈於香港交易所GEM上市計劃。於發售量調整權行使前,公司計劃發售100,000,000股股份,其中90%為配售,其餘10%為公開發售。每股發售價0.45港元至0.65港元,預計集資約45百萬港元至65百萬港元。公開發售認購申請將於2025年9月30日開始,於2025年10月6日中午12時正(香港時間)截止。分配結果將不遲於2025年10月9日公佈。金葉國際的股份預計於2025年10月10日正式掛牌,股份代號為8549,每手為5,000股。同人融資有限公司為是次股份發售之獨家保薦人,同人融資有限公司及民銀證券有限公司為聯席整體協調人,同人融資有限公司、民銀證券有限公司、興證國際融資有限公司、第一上海證券有限公司、百惠證券有限公司、輝立證券(香港)有限公司、南華證券證券投資有限公司、浦銀國際融資有限公司以及盈立證券有限公司為聯席賬簿管理人及聯席牽頭經辦人。金葉國際是香港機電工程行業老牌承建商,擁有近20年行業經驗,專注於暖氣、通風及冷氣調節系統工程,包括供應、安裝、保養及維修服務,佔公司收入超過90%;同時,公司亦從事電力裝置及給供水系統工程。在過去兩個年度,集團分別完成超過1,000個不同規模的項目。2025年3月31日止年度,比上一財年,集團的收益增加約25.6%至約154.5百萬港元,年內利潤亦增加約35.7%至約14.1百萬港元,毛利率及淨利潤率分別為約20.4%及9.1%。於截至2025年7月31日,集團手上擁有187個項目,未完成訂單價值約為62.8百萬港元。此外,集團亦已獲得一項目續期,項目由2025年9月起為期三年,合約金額預計不少於50百萬港元。集團與香港大型的物業管理公司已維持許多年業務關係。於2023/24年度及2024/25年度,公司的五大客戶總收入分別佔集團總收入約64.5%及68.1%。集團服務的物業組合遍佈香港島、九龍及新界,包括大角咀的奧海城、尖沙咀的中港城、荃灣的荃新天地、銅鑼灣的恒隆中心、銅鑼灣的Fashion Walk、山頂的山頂廣場、北角的友邦廣場、大角咀的港灣豪庭廣場、中環的中環中心、鰂魚涌的太古坊、啟德的AIRSIDE及紅磡的都會大廈。管理團隊經驗豐富,熟識機電工程行業的發展。董事會主席、行政總裁、執行董事及公司創辦人之一葉金弋先生,在機電工程行業擁有超過20年的深厚經驗。執行董事及公司創辦人之一呂國傑先生擁有超過30年的機電工程行業經驗,具備豐富的實戰經驗。 集團研發雲端定製系統「GL ERP」系統推動高效項目管理,涵蓋投標準備及審批、項目進度監察以及財務管理。此外,公司實施嚴格的運作體系,符合國際標準,並已獲得ISO 9001:2015(質量管理系統)、ISO 14001:2015(環境管理系統)及ISO 45001:2018(職業健康與安全管理體系)的全面認證。受香港老舊樓宇改造、可持續發展計劃及智能及綠色樓宇技術進步推動,香港暖氣、通風及冷氣調節工程的市場規模增長強勁。私營領域為增長的主要驅動因素,預計將於2025年至2029年期間按複合年增長率約5.8%增長,並於2029年達約8,318.3百萬港元,反映對升級及智能暖氣、通風及冷氣調節技術的穩定增長需求。公司擬將有關發售所得款項撥作以下用途: 56.1%為新項目的前期成本提供資金、32.6%為新員工招聘及租賃額外辦公室、1.3%為升級公司的「GL ERP」系統及10%為一般營運資金。新聞垂詢:縱橫財經公關顧問(中國)有限公司張麗雲小姐 電話:(852) 2864 4827張嘩雲小姐 電話:(852) 2864 4830姚婉婷小姐 電話:(852) 2864 4897電郵 sprg-goldenleaf@sprg.com.hk Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Golden Leaf International Group Limited Announces Listing Plan On GEM Of Hong Kong Stock Exchange ACN Newswire

Golden Leaf International Group Limited Announces Listing Plan On GEM Of Hong Kong Stock Exchange

Investment Highlights:- Golden Leaf International is an established E&M (Electrical and Mechanical) engineering contractor with almost 20 years of extensive industry experience, specializing in supply, installation and maintenance of HVAC systems which contributes to over 90% of the Group’s revenue.- For each of the past two financial years, the Group completed over 1,000 projects at different scales. As at 31 July 2025, the Group had 187 projects on hand with backlog value of approximately HK$62.8 million. In addition, the Group has renewed a project for a term of three years commencing from September 2025 with a contract sum expected to be no less than HK$50 million.- For the year ended 31 March 2025, the Group’s revenue increased by approximately 25.6% year-on-year to approximately HK$154.5 million, and the Group’s profit for the year increased by approximately 35.7% to approximately HK$14.1 million. For the year ended 31 March 2025, the Group’s gross profit margin and net profit margin were approximately 20.4% and 9.1%, respectively.- The Group has established business relationships as a main contractor with a wide range of sizeable property managers, reinforcing its solid market position.- The management team has extensive experience in the E&M engineering industry, with Executive Directors boasting over 20-30 years of industry experience.- The Group has developed a cloud-based and customized system “GL ERP” to facilitate efficient project management.- The Group has implemented strict operation systems complying with international standards and certified with ISO 9001:2015 (Quality Management), ISO 14001:2015 (Environmental Management) and ISO 45001:2018 (Occupational Health and Safety Management).HONG KONG, Sep 30, 2025 - (ACN Newswire via SeaPRwire.com) – Golden Leaf International Group Limited ("Golden Leaf International" or the "Company", together with its subsidiaries, the “Group”), a well-established electrical and mechanical ("E&M") engineering contractor in Hong Kong, today announced its listing plan on GEM of Hong Kong Stock Exchange.Before exercising the Offer Size Adjustment Option, the Company plans to offer 100,000,000 shares, with 90% allocated to the Placing and 10% to the Public Offer, at the Offer Price ranging from HK$0.45 to HK$0.65 per Offer Share, which is expected to raise a fund of approximately HK$45 million to HK$65 million.The Public Offer is expected to commence on 30 September 2025 and close at 12:00 noon on 6 October 2025. The allocation results are expected to be announced on or before 9 October 2025. Trading of the Company's shares on GEM is expected to commence on 10 October 2025 under the stock code 8549, with a board lot size of 5,000 shares.Alliance Capital Partners Limited is the Sole Sponsor for the listing. Alliance Capital Partners Limited and CMBC Securities Company Limited are the Joint Overall Coordinators. Alliance Capital Partners Limited, CMBC Securities Company Limited, China Industrial Securities International Capital Limited, First Shanghai Securities Limited, Patrons Securities Limited, Phillip Securities (Hong Kong) Limited, South China Securities Limited, SPDB International Capital Limited and uSmart Securities Limited are Joint Bookrunners and Joint Lead Managers.Golden Leaf International is an established E&M engineering contractor in Hong Kong with almost 20 years of industry experience, specialising in HVAC systems works, which accounted for over 90% of the Group’s revenue. The Group also undertakes electrical systems works, and plumbing and drainage systems works.For each of FY2023/24 and FY2024/25, the Group completed over 1,000 projects at different scales. For the year ended 31 March 2025, the Group’s revenue increased by approximately 25.6% to approximately HK$154.5 million, and profit for the year increased by approximately 35.7% to approximately HK$14.1 million, compared to the previous financial year. The gross profit margin and net profit margin were 20.4% and 9.1%, respectively, for FY2024/25. As at 31 July 2025, the Group had 187 projects on hand with a backlog value of approximately HK$62.8 million. In addition, the Group has renewed a project for a term of three years commencing from September 2025 with a contract sum expected to be no less than HK$50 million.The Group has maintained many years of business relationships with sizable property managers in Hong Kong. Revenue from the top five customers accounted for approximately 64.5% and 68.1% of the Group’s total revenue for the years ended 31 March 2024 and 2025, respectively.The Group’s project portfolio covers commercial properties across Hong Kong Island, Kowloon and the New Territories, including Olympian City in Tai Kok Tsui, China Hong Kong City in Tsim Sha Tsui, Citywalk in Tsuen Wan, Hang Lung Centre in Causeway Bay, Fashion Walk in Causeway Bay, Peak Galleria at the Peak, AIA Tower in North Point, Metro Harbour Plaza in Tai Kok Tsui, The Center in Central, Taikoo Place in Quarry Bay, AIRSIDE in Kai Tak and the Metropolis Tower in Hung Hom.The Company’s management team is experienced and up-to-date with the development of the E&M engineering industry. Mr. Ip Kam Yik, the Chairman of the Board, Chief Executive Officer, Executive Director and one of the founders of the Company, has over 20 years of experience in the E&M engineering industry. Mr. Lui Kwok Kit, Executive Director and one of the founders of the Company, has over 30 years of experience in the E&M engineering industry with extensive on-the-ground experience.The Group has developed a cloud-based "GL ERP" system to facilitate efficient project management, covering tender preparation and approval, project progress monitoring and financial management. Moreover, the Company has implemented strict operation systems complying with international standards and fully certified with ISO 9001:2015 (Quality Management), ISO 14001:2015 (Environmental Management) and ISO 45001:2018 (Occupational Health and Safety Management).The market size for HVAC works in Hong Kong has shown robust growth, driven by urban renewal, sustainability initiatives, and technological advancements. The private sector has been the dominant driver of this growth, expected to grow at a CAGR of approximately 5.8% from 2025 to 2029 reaching approximately HK$8,318.3 million by 2029, reflecting steady demand for upgrades and smart HVAC technologies.The Company intends to use the net proceeds from the Share Offer as follows: approximately 56.1% to finance up-front costs for new projects; approximately 32.6% for recruiting new staff and leasing an additional office; approximately 1.3% for upgrading the "GL ERP" system; and approximately 10% for general working capital purposes.Media Enquiries:Strategic Financial Relations (China) LimitedMs. Anita CHEUNG Tel: (852) 2864 4827Ms. Coco ZHANG Tel: (852) 2864 4830Ms. Alison YIU Tel: (852) 2864 4897Email: sprg-goldenleaf@sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
普源精電遞表港交所:衝刺中國電子測量儀器「A+H」第一股 ACN Newswire

普源精電遞表港交所:衝刺中國電子測量儀器「A+H」第一股

香港,2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 9月29日,國內電子測量儀器領軍企業普源精電(688337.SH)H股上市正式遞表,擬實現「A+H」兩地上市,獨家保薦人為中信證券。根據弗若斯特沙利文報告,普源精電是中國最大的電子測量儀器供應商。與此同時,2024年中國共三家電子測量企業躋身全球營收前十名業者之列,其中普源精電成為排名最高的中國企業。普源精電的產品及解決方案主要服務於通信、新能源、半導體以及教育與科研領域等多元化的終端市場,已為90多個國家和地區超過100,000名終端客戶提供服務。全球電子測試測量市場正迎來技術迭代與需求爆發的雙重紅利,預計2025年至2029年間的複合年增長率達到8.6%,達約人民幣1700億元。在行業發展與技術突破的雙重利好下,普源精電有望以「A+H」上市為契機,進一步鞏固國內龍頭地位,加速成為全球電子測量儀器領域的重要力量。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Bamboos Announces 2025 Annual Results ACN Newswire

Bamboos Announces 2025 Annual Results

HONG KONG, Sep 29, 2025 - (ACN Newswire via SeaPRwire.com) – Bamboos Health Care Holdings Limited ("Bamboos" or the "Group", Stock Code: 2293) announced its annual results for the year ended 30 June 2025 (the "Period" or the "Year") on September 30th. The Group's overall business remained stable during the year, continuing its consistent focus on shareholder returns, and declared a final dividend for 2025 of HK1.50 cents per ordinary share.During the Period, the Group's revenue was approximately HK$74.4 million. The revenue from the provision of healthcare staffing solution services was approximately HK$61.7 million, comprising approximately HK$35.2 million from institutional staffing solution services and approximately HK$26.5 million from private nursing staffing services. Other income increased year-on-year to HK$1.6 million. Profit before income tax was approximately HK$22.4 million. Profit attributable to equity holders of the Company for the year amounted to approximately HK$17.5 million. Finance income increased year-on-year to approximately HK$1.6 million for the year. Total assets remained stable, with current assets maintaining a healthy level.Furthermore, during the year, the Group also utilized idle cash balances to acquire SPDR Gold Trust, which is a standalone investment trust and an exchange trade fund which holds gold bullion (the "Acquisitions"), enhancing the efficiency of utilizing the Group's idle cash. The Board considers that the Acquisitions provide the Group with opportunity to balance and diversify its investment portfolio, as well as protecting the Group from currency debasements and inflation in times of uncertainty.As of 30 June 2025, the number of healthcare personnel registered with the Group increased by 7.4% year-on-year to approximately 32,000, from 29,800 in the same period last year. This steadily growing, large, and diverse pool of registered healthcare personnel not only demonstrates the Group's favorable benefits and talent retention rate but will also help the Group further enhance its competitive strength and seize business development opportunities.Actively Advances Integration of 'Technology+Innovation' with Healthcare, New 'Bamboos Health' Ecosystem Holds Broad Development SpaceWith healthcare staffing solutions at its core, Bamboos provides professional, comprehensive, reliable, and customized institutional support services and home care nursing solutions for the Hospital Authority, private hospitals, social welfare organizations, clinics, and research medical institutions. While steadfastly maintaining its core business in recent years, the Group has actively promoted the integration of "Technology + Innovation" with healthcare, continuously optimizing service quality and efficiency, deepening business cooperation, and expanding business scope. By integrating three major service sectors – Preventive Medicine, Chinese and Western Medical Services, and Smart Elderly Care and Age-Friendly Living Solutions – the Group has built a new "Bamboos Health" ecosystem.During the year, the Group also actively utilized its self-owned physical space in Mong Kok, and has established a service platform integrating healthcare, smart home AI elderly care technology, and data – "healtHUB". It has evolved from initially providing healthcare staffing solutions into a health technology ecosystem platform covering the full lifecycle of "Prevention-Treatment-Rehabilitation-Home Care-Smart Elderly Care", providing a one-stop healthcare and smart home service solution empowered by "Technology + Innovation".Given the ongoing trends of population ageing and healthcare manpower shortages, coupled with the broad prospects of the global AI healthcare market, Bamboos' focus on "Technology + Innovation" empowerment and its business coverage of the full lifecycle aligns with healthcare industry development trends. Simultaneously, the Group actively responds to national and government policies, echoing China's "Healthy China 2030" Plan Outline and supporting the development of Hong Kong's Primary Healthcare system. This not only allows multiple business lines to benefit from long-term policy support and access stable government business resources but also creates synergies with other operations, presenting Bamboos Health Care with extensive, stable business demand and medium-to-long-term sustainable growth potential.Ms. Hai Hiu Chu, Chairman and Chief Executive Officer of Bamboos Group, said, "Bamboos will continue to dedicate itself to strengthening and consolidating its core business and becoming a more renowned market leader, while actively seeking new business opportunities, advancing the integration of 'Technology + Innovation' with healthcare, and forming alliances or partnerships with strategic collaborators to pursue greater diversification of the Group's business, supporting Bamboos' sustainable growth and the strategy of maximizing shareholder returns."About Bamboos Health Care Holdings LimitedBamboos Health Care Holdings Limited provides a one-stop healthcare and smart home service solution empowered by "Technology + Innovation". Since its establishment in 2009, the Group has always adhered to the service philosophy of "Care • Competence • Commitment". In recent years, while steadfastly maintaining its core business, the Group has promoted the integration of "Technology + Innovation" with healthcare, continuously optimizing service quality and efficiency, deepening business cooperation, and expanding business scope. By integrating three major service sectors – Preventive Medicine, Chinese and Western Medical Services, and Smart Elderly Care and Age-Friendly Living Solutions – the Group has built a new "Bamboos Health" ecosystem. The Group also actively utilized its self-owned physical space in Mong Kok, establishing a service platform integrating healthcare, smart home AI elderly care technology, and data – " healtHUB". The Group has now evolved from initially providing healthcare staffing solutions into a health technology ecosystem platform covering the full lifecycle of "Prevention-Treatment-Rehabilitation-Home Care-Smart Elderly Care".With healthcare staffing solutions at its core, Bamboos boasts a network of over 32,000 qualified professional healthcare personnel, providing professional, comprehensive, reliable, and customized institutional support services and home care nursing solutions for the Hospital Authority, private hospitals, social welfare organizations, clinics, and research medical institutions. To date, the Group has served over 3,500 nursing homes / rehabilitation centres / clinics. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
百本公佈2025全年業績 積極推進「科技+創新」與醫療健康的融合 ACN Newswire

百本公佈2025全年業績 積極推進「科技+創新」與醫療健康的融合

香港,2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 百本醫護控股有限公司(「百本」或「集團」,股份代號:2293)於9月26日宣佈截至2025年6月30日止年度(「期內」或「年內」)業績。年內總體業務保持穩定,延續連年對股東回報的重視,宣派2025年度末期股息每股普通股1.50港仙。期內,集團收益約為7,440萬港元,其中提供醫護人手解決方案服務所得的收益約為6,170萬港元,機構人手解決方案服務所得收益及私家看護人手配置服務所得收益分别为約3,520萬港元及約2,650萬港元;其他收入同比增加至為160萬港元;除所得稅前溢利約2,240萬港元;公司權益持有人應佔本年度溢利約為1,750萬港元;財務收入同比增加至本年度的約160萬港元;總資產保持穩定,流動資產維持健康水平。此外,集團年內亦動用閒置現金結餘收購單一投資信託及持有金錠的交易所買賣基金,SPDR金ETF(「該等收購事項」),提升集團閒置現金的使用效益。董事會相信,該等收購事項可為集團提供平衡及分散投資組合的機會,及抗衡貨幣貶值及通貨膨脹。截至2025年6月30日,集團已登記醫護人員數目較去年同期的29,800名同比增加7.4%至約32,000名,穩步增長且龐大而多元化的登記醫護人員規模不僅顯示集團良好的待遇及人才留存率,並將有助集團進一步增強競爭實力,把握業務發展機遇。積極推進「科技+創新」與醫療健康的融合 全新「百本健康」生態具廣闊發展空間以醫療人手解决方案爲核心,百本可爲醫院管理局、私家醫院、社福機構、診所及科研醫療機構提供專業、全面、可靠和客製化的醫療機構支援服務及居家養老醫護人手解決方案。近年集團在堅守核心業務的同時,積極推進「科技+創新」與醫療健康的融合,持續優化服務質素和效率、加深業務合作及拓展業務內容,整合預防醫學、中西醫療、智慧養老及適老化生活解决方案三大服務板塊,構建了全新的「百本健康」生態。年內,集團亦積極利用旺角自購實體空間,現已構建了一個集醫療保健及智慧居家人工智能養老科技和數據的服務平台——「healtHUB」,已從最初的提供醫護人手解決方案發展成爲覆蓋「預防-治療-康復-居家照護-智慧養老」全生命周期的健康科技生態平台,提供「科技+創新」賦能的一站式醫療健康及智慧居家服務解决方案。現時人口老齡化及醫療人手短缺趨勢持續,全球AI醫療市場前景廣闊,百本聚焦「科技+創新」賦能,業務已覆蓋符合醫療健康行業發展趨勢的全生命周期。同時,集團積極響應國家及政府政策,呼應國家的《「健康中國2030」規劃綱要》,並支持香港政府基層醫療健康系統發展,不僅多項業務受益於政策的長期支持,亦可獲得穩定的政府業務資源,並可與其他業務形成協同效應,均可為百本帶來廣泛、穩定的業務需求及中長期持續增長空間。百本集團主席兼行政總裁奚曉珠小姐表示:「百本將繼續致力於加強及鞏固核心業務及成為更加知名的市場領導者,同時積極尋求新業務機會,推進『科技+創新』與醫療健康的融合,與戰略合作夥伴結盟或合作以追求提高集團業務的多元化程度,為百本的可持續增長及股東回報最大化的策略提供支持」。關於百本醫護控股有限公司百本醫護控股有限公司提供「科技+創新」賦能的一站式醫療健康及智慧居家服務解决方案。集團自2009年創立以來,始終秉持「關懷備至」、「專業實幹」、「全心全意」的服務理念,近年在堅守核心業務的同時,推進「科技+創新」與醫療健康的融合,持續優化服務質素和效率、加深業務合作及拓展業務內容,整合預防醫學、中西醫療、智慧養老及適老化生活解决方案三大服務板塊,構建了全新的「百本健康」生態。集團亦積極利用旺角自購實體空間,現已構建了一個集醫療保健及智慧居家人工智能養老科技和數據的服務平台——「healtHUB」。集團目前已從最初的提供醫護人手解決方案發展成爲覆蓋「預防-治療-康復-居家照護-智慧養老」全生命周期的健康科技生態平台。以醫療人手解决方案爲核心,百本擁有超過32,000名合資格專業醫護人才網絡,可爲醫院管理局、私家醫院、社福機構、診所及科研醫療機構提供專業、全面、可靠和客製化的醫療機構支援服務及居家養老醫護人手解決方案。至今,集團已服務超過3,500家老人院/康復中心/診所。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
周大福人壽40週年呈獻「飛揚 ‧ 盛世」儲蓄壽險計劃 ACN Newswire

周大福人壽40週年呈獻「飛揚 ‧ 盛世」儲蓄壽險計劃

香港,2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 周大福人壽宣佈,為慶祝成立40週年,推出全新「飛揚 ‧ 盛世」儲蓄壽險計劃(「飛揚 ‧ 盛世」),以「動靜皆宜」為設計理念,兼顧靜態滾存增值與動態提取資金的需要,配合市場特有1「財富增值調配選項」2,特別提供「增進」、「均衡」及「保守」三個選項供客戶作靈活調配,計劃亦設有「保單分拆選項」3及「保單雙傳承」等優勢,為客戶實現長遠財富規劃與跨代傳承目標。「飛揚 ‧ 盛世」為2年保費繳付年期的美元儲蓄壽險計劃,客戶於指定日期內成功投保,並以一筆過形式清繳保費,預繳保費除可獲派基本年利率之利息外,更可享額外年利率之利息,保證預繳保費利率高達10.1%4。周大福人壽首席產品總監關珮妍表示:「理想的財富管理策略,不僅在於持續累積,更關鍵在靈活管理與高效增值。適逢今年是周大福人壽成立40週年,我們特意推出限時發售的『飛揚・盛世』,此產品不僅鞏固了我們在儲蓄壽險領域的領先地位,更是協助客戶實現財富自主與傳承規劃的重要工具。『飛揚・盛世』融合多項的靈活選項,讓客戶既可累積財富,又可提取保單價值以應對生活所需,充分展現我們致力提供更個人化、更具前瞻性的財策方案,並體現開創保險新價值的堅定承諾。」「飛揚 ‧ 盛世」的優越特點包括:1.「財富增值調配選項」2:市場特有1的調配選項,讓客戶於第10個保單週年日開始,輕鬆以「增進」、「均衡」及「保守」這三個預設的調配選項,靈活挑選「穩健資產戶口」5的價值與復歸紅利6之現金價值(如有)及終期分紅7之現金價值(如有)分配比例。2.保單分拆選項3:由第5個保單年度完結後起,客戶可於每個保單年度分拆保單,把現有保單的部分投保單位分配至一份獨立「分拆保單」,保單分拆選項3亦適用於分拆保單,極致發揮資產分配功能。3.保單雙傳承方案:客戶可於保單第6個保單週月日起無限次轉換受保人8,計劃另外設有「保單延續選項」9,讓指定受益人9於受保人身故後成為新保單持有人(如適用)及新受保人,讓保單繼續傳承。兩個產品特點的保障期亦將調整至新受保人128歲,讓保單可以享有充足的財富增值期,做到無限延續,世代相傳。4.保費豁免保障10:若受保人為18歲或以上10並同時為保單持有人,於75歲前因意外受傷而導致完全永久傷殘11,其基本計劃的未來保費將按「保費豁免保障10」而獲豁免。若受保人為17歲或以下10,而保單持有人(包括後補保單持有人12)於75歲前因意外受傷而導致完全永久傷殘11或不幸身故,其基本計劃的未來保費亦可按「付款人保費豁免保障」而獲豁免10。以上保費豁免更高達500,000美元,豁免期直至保費期滿日或達到豁免金額上限,保障客戶遭遇不幸時維持保單生效,守護摯愛家人。5.自選身故賠償13 / 全數退保14支付方式:客戶可為每位受益人從5種選項中選擇其中一項身故賠償支付,其中包括一筆過、固定分期13、遞增分期13,亦可以選部份以一筆過支付後餘額以遞增分期方式支付,或者自訂指定年期或於受益人指定的年歲開始以定額或遞增分期支付,讓每位受益人獲得最合適的安排。當保單生效5年後,保單持有人若選擇全數退保14,除了一筆過形式外,亦可選擇以定期給付或遞增給付方式領取退保款項14,靈活配合需要。6.預繳保費為財富增值效益:「飛揚 ‧ 盛世」為2年保費繳付年期計劃,客戶可於投保時選擇一筆過預繳保費15,以較低的成本完成保費供款,而預繳之保費15更可獲享利息16(如有)。註:1.「市場特有」之計劃特點為比較香港主要人壽保險公司同類主要儲蓄壽險產品後所得出之結果,截至2025年9月26日。2.財富增值調配選項及其分配比例:調配選項「穩健資產戶口」分配比例復歸紅利之現金價值(如有)及終期分紅之現金價值(如有)分配比例「增進」0%100%「均衡」40%60%「保守」80%20%「穩健資產戶口分配比例」 =「穩健資產戶口」價值 ÷ (復歸紅利之現金價值(如有)及終期分紅之現金價值(如有)+ 穩健資產戶口價值之總額)x 100%。於第10個保單週年日及其後的保單週年日前或之後的30日內,在符合本公司當時的通行規則下,客戶行使財富增值調配選項以達至客戶所選擇之調配選項的相應穩健資產戶口分配比例,惟須符合特定條件,請參閱保單條款以了解更多關於財富增值調配選項之詳情。3.在計劃有效期內及由第5個保單年度終結後起,保單持有人可行使保單分拆選項以建立一份獨立的保單(「分拆保單」),從保單的基本計劃中分配某部分的投保單位至分拆保單而毋須提供可保證明,惟須符合特定條件。分拆保單只會在其保單條款及保單資料說明發出後生效。請參閱保單條款以了解更多關於保單分拆選項之詳情。4.投保申請遞交日期為2025年9月26日至2025年11月28日(包括首尾兩天)。詳情請參閱宣傳單張: https://www.ctflife.com.hk/pdf/tc/regent-leap-prepaid-premium-promotion-flyer.pdf5.穩健資產戶口的長期目標資產配置為100%固定收入類別證券。穩健資產戶口之價值將會按不時公佈的利率積存生息。穩健資產戶口之利率並非保證,並可能會在任何年度為0%。6.復歸紅利之面值及現金價值並非保證。然而一經公佈,該公佈之復歸紅利之面值便成為保證,並會永久附加於保單。請參閱保單條款以了解更多關於復歸紅利之詳情。7.由第1個保單週年日起,本公司可就此計劃公佈非保證終期分紅,且本公司對決定是否派發該非保證終期分紅及其金額有唯一的酌情決定權。終期分紅之現金價值將會相等於或少於終期分紅之面值。8.轉換受保人須符合指定條件和當時的行政規定。投保單位、保證現金價值、累積復歸紅利之面值(如有)、終期分紅之面值(如有)、任何穩健資產戶口之累積價值、保單日期及保單年度將在轉換受保人生效日期當日保持不變,而期滿日將更改為轉換新受保人128歲生日當天或緊接其後的保單週年日(以適用者為準)。請參閱保單條款以了解更多關於轉換受保人選項之詳情。9.於受保人身故時,若保單持有人(仍在生)與受保人非同一人,受益人將成為延續新受保人。而於受保人身故時,若保單持有人同時身故或保單持有人與受保人為同一人,受益人將成為新保單持有人及延續新受保人,惟該受益人須符合當時公司的行政規定。於行使此選項後,投保單位、已繳付保費總額、保證現金價值、累積復歸紅利之面值(如有)、終期分紅之面值(如有)及穩健資產戶口之累積價值(如有)、保單日期和保單年度將在保單延續生效日期當日維持不變,但保單的基本計劃之計劃期滿日將調整至延續新受保人128歲生日當天或緊接其後的保單週年日(以適用者為準),請參閱保單條款以了解更多關於保單延續選項之詳情。10.保費豁免保障有兩類安排:(i)「保費豁免保障」適用於受保人同時為保單持有人,於保單繕發或轉換受保人時最新之受保人須為18至60歲,並不幸在75歲前因意外受傷而確診完全永久傷殘。(ii)「付款人保費豁免保障」適用於保單繕發或轉換受保人時,最新之受保人年齡為17歲或以下;於保單繕發或轉換保單持有人(包括後補保單持有人)時,最新之保單持有人(包括後補保單持有人)須年屆60歲或以下,並不幸在75歲前因意外受傷確診完全永久傷殘或身故。請參閱保單條款以了解更多關於「保費豁免保障」及「付款人保費豁免保障」之詳情。11.完全永久傷殘指因受傷而發生下列任何一項情況:(i)雙眼全面且無法恢復的喪失視力;或(ii)兩肢肢體完全和永久癱瘓,或在兩肢的手腕或腳踝處或其手腕或腳踝之上方實際切斷;或(iii)一隻眼睛的全面且無法恢復的喪失視力以及一肢體的完全和永久癱瘓或在一肢的手腕或腳踝處或其手腕或腳踝之上方實際切斷。12.後補保單持有人指由保單持有人於本公司的投保書或其後於本公司指定表格上指定並獲本公司批准為後補保單持有人的人士。請參閱保單條款以了解更多關於後補保單持有人之詳情。13.須符合特定條件,請參閱保單條款以了解更多關於身故賠償支付選項之詳情。14.須符合特定條件,請參閱保單條款以了解更多關於全數退保之詳情。15.預繳保費選項只適用於年繳保費模式的保單。預繳之保費將會存入保費儲存戶口,已存於保費儲存戶口之款項會按當時本公司所給付之利率獲派利息(現時年利率為2厘,惟此利率並非保證),您可以全數提取保費儲存戶口內之預繳保費,但所得之利息會被收回。如保費儲存戶口之款項由於利率下降而不足以繳付保費及保費徵費,保單持有人需補回有關保費差額(包括保費徵費),否則保單會被終止或被執行自動保費貸款。如受保人身故,保費儲存戶口內的餘額(如有)會給付保單持有人,並不會收取手續費。16.此利息現時為年利率2%且為非保證的。重要提示:- 本新聞稿乃資料摘要,僅供參考之用。詳情請參閱有關產品小冊子、宣傳單張及保單文件。有關周大福人壽「飛揚 ‧ 盛世」儲蓄壽險計劃詳情,均以保單合約之條款及細則作準。- 本新聞稿的產品資料不包含「飛揚 ‧ 盛世」儲蓄壽險計劃的完整條款,有關完整條款載於保單文件中。上述「飛揚 ‧ 盛世」儲蓄壽險計劃可作為獨立保單而無須捆綁式地與其他種類的保險產品一併購買。敬請務須參閱有關「飛揚 ‧ 盛世」儲蓄壽險計劃之主要產品推銷刊物、保單條款及由閣下的持牌保險中介人所陳述之說明文件以全面了解關於以上定義、收費、產品特點、不保事項及賠償給付條件等之詳情及完整條款及細則。- 有關「飛揚 ‧ 盛世」儲蓄壽險計劃產品小冊子,請瀏覽 : https://www.ctflife.com.hk/pdf/tc/regent-leap-savings-insurance-plan-brochure.pdf- 如欲查詢,歡迎致電周大福人壽客戶服務熱線:+852 2866 8898。- 本新聞稿只適宜於香港分發,不應被詮釋為在香港以外地區提供周大福人壽的任何產品,或就其作出要約或招攬。如在香港境外之任何司法管轄區的法律下提供或出售或游說購買任何周大福人壽的產品屬違法,周大福人壽在此聲明無意在該司法管轄區提供或出售或游說購買該產品。關於周大福人壽周大福人壽保險有限公司(「周大福人壽」)扎根香港40年,為周大福創建有限公司(「周大福創建」)(香港股份代號:659)的全資附屬公司,也是香港最具規模的壽險公司之一。作為周大福企業成員,周大福人壽緊扣鄭氏家族(「周大福集團」或「集團」)生態圈的雄厚資源,致力為客戶及其摯愛於「生活、成長、健康、傳承」的人生旅程中,提供個人化的匠心規劃、終身保障及優質體驗。憑藉集團財務實力及環球投資佈局,周大福人壽矢志成為亞太區領先的保險公司,持續開創保險新價值。傳媒聯絡周大福人壽企業傳訊部莊啟恩+852 2591 8427anki.chong@ctflife.com.hk周大福人壽保險有限公司(於百慕達註冊成立之有限公司) Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
31 Concept 透過策略性收購 Xynthor AI 加速次世代 DPI 領導地位 ACN Newswire

31 Concept 透過策略性收購 Xynthor AI 加速次世代 DPI 領導地位

迪拜,阿聯酋, 2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 阿聯酋領先的網路安全創新企業 31 CONCEPT (31C) 今日宣布,已策略性收購加拿大公司 Xynthor AI Software Inc.,該公司在 AI 原生資料外洩防護(Data Loss Prevention, DLP)解決方案領域具開創性。此次收購將進一步鞏固 31C 致力推動深度封包智慧(Deep Packet Intelligence, DPI)、企業安全,以及在 AI 為核心的世界中維護資料主權的承諾。31 Concept 與 Xynthor透過整合 Xynthor 的「AI 時代 DLP」與 31C 在 DPI 領域的專業,雙方的結合平台將提供市場上最完整的 AI 感知型安全解決方案。此舉正面回應了現代 AI 驅動工作流程 對能夠應對的新一代安全系統日益增長的需求。為什麼這很重要生成式 AI 工具(如 ChatGPT 與 Claude)的崛起,已遠遠超越傳統 DLP 系統的能力,而這些系統僅針對結構化資料與靜態規則而設計。高知名度的事件——例如 三星工程師在使用 ChatGPT 時意外洩露專有原始碼——凸顯了建立 專為 AI 設計的安全防護 的迫切性。31C 執行長 Misha Hanin 強調:「AI 與網路安全的匯聚,是我們產業史上最重大的典範轉移。傳統方法無法處理今日 AI 環境中動態、具語境感知的資料流。透過此次收購,我們正在開創一個全新的 AI 原生安全解決方案 類別。」Xynthor 的突破性技術Xynthor 帶來幾項獨特的差異化:AI 資料守護者:透過 NLP 驅動的偵測,防止敏感資訊離開組織。隔離式架構:將分析保持在客戶環境內,確保隱私與合規性。情境感知智慧:透過 AI 驅動的分類與行為分析,減少誤判。私有 LLM 保護:讓內部大型語言模型能安全使用,而不會暴露於外部。無縫整合:可與既有基礎設施配合運作,同時支援 HIPAA 和 GDPR 等法規。全面性的 AI 時代平台整合的平台透過即時政策管理、自適應威脅偵測與行為分析,強化 DPI。它同時簡化了符合 GDPR、HIPAA、PCI DSS 以及即將推出的 AI 治理標準的流程。31C 技術長 Boris Heismann 表示:「我們不僅在回應當前的需求,也在預見未來的挑戰。將 DPI 與 AI 原生 DLP 結合,創造出一個為未來做好準備的安全平台。」策略影響全球資料外洩的平均成本每次超過 400 萬美元,而 AI 驅動的風險只會持續增加。透過結合 DPI 與 AI 原生 DLP,31C 定位自己為能解決這些關鍵挑戰的全球領導者。此次收購符合 31C 的成長策略,其中包括與 Xynthor 產品成功掛鉤的績效獎勵。兩家公司將繼續在阿聯酋與加拿大營運,結合雙方優勢,加速創新與市場拓展。關於 31C31C 成立於阿聯酋,是一家專注於深度封包智慧(DPI)、企業安全與資料主權的網路安全公司。其創新的方法使其成為全球企業、政府及監管機構信賴的合作夥伴。關於 Xynthor AIXynthor AI 總部位於加拿大,開發 AI 原生安全平台,旨在保護使用生成式 AI 的組織,確保在 AI 時代的安全與合規。欲了解更多有關 31C 次世代 DPI 解決方案的資訊,請造訪 https://31c.io 。聯絡資訊Misha HaninCEOmisha.hanin@31c.io來源: 31 Concept Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
31 Concept Accelerates Next-Gen DPI Leadership With Strategic Acquisition of Xynthor AI ACN Newswire

31 Concept Accelerates Next-Gen DPI Leadership With Strategic Acquisition of Xynthor AI

DUBAI, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - 31 CONCEPT (31C), a leading UAE-based cybersecurity innovator, today announced the strategic acquisition of Xynthor AI Software Inc., a Canadian company pioneering AI-native Data Loss Prevention (DLP) solutions. This acquisition strengthens 31C's commitment to advancing Deep Packet Intelligence (DPI), corporate security, and data sovereignty in an AI-centric world.31 Concept & XynthorBy integrating Xynthor's "DLP for AI Era" with 31C's DPI expertise, the combined platform will deliver the most comprehensive AI-aware security solution available. This move addresses the growing need for security systems capable of handling modern AI-driven workflows.Why It MattersThe rise of generative AI tools such as ChatGPT and Claude has outpaced the capabilities of traditional DLP systems, which were built for structured data and static rules. High-profile incidents, including the accidental leakage of proprietary source code by Samsung engineers using ChatGPT, highlight the urgent need for AI-specific safeguards.Misha Hanin, CEO of 31C, emphasized: "The convergence of AI and cybersecurity is the most significant paradigm shift our industry has ever seen. Traditional methods cannot manage the dynamic, context-aware data flows of today's AI environments. Through this acquisition, we are pioneering an entirely new category of AI-native security solutions."Xynthor's Breakthrough TechnologyXynthor brings several unique differentiators:AI Data Guardian: Prevents sensitive information from leaving the organization using NLP-driven detection.Air-Gapped Architecture: Keeps analysis inside the client's environment, ensuring privacy and compliance.Context-Aware Intelligence: Reduces false positives through AI-driven classification and behavioral analysis.Private LLM Protection: Enables safe use of internal large language models without external exposure.Seamless Integration: Works with existing infrastructure while supporting regulations like HIPAA and GDPR.Comprehensive AI-Era PlatformThe integrated platform enhances DPI with real-time policy management, adaptive threat detection, and behavioral analytics. It also streamlines compliance with GDPR, HIPAA, PCI DSS, and upcoming AI governance standards.Boris Heismann, CTO of 31C, stated: "We're not only responding to current demands but anticipating tomorrow's challenges. Combining DPI with AI-native DLP creates a future-ready security platform."Strategic ImpactThe global cost of data breaches averages over $4 million per incident, and AI-driven risks are only increasing. By uniting DPI and AI-native DLP, 31C positions itself as a global leader capable of addressing these critical challenges.This acquisition aligns with 31C's growth strategy, including performance-based incentives tied to Xynthor's product success. Both companies will continue to operate from the UAE and Canada, combining their strengths to accelerate innovation and market expansion.About 31CFounded in the UAE, 31C is a cybersecurity company specializing in Deep Packet Intelligence, corporate security, and data sovereignty. Its innovative approach makes it a trusted partner for enterprises, governments, and regulators worldwide.About Xynthor AIBased in Canada, Xynthor AI develops AI-native security platforms designed to protect organizations using generative AI, ensuring both safety and compliance in the AI era.For more information about 31C's Next Gen DPI solutions, visit https://31c.io.Contact InformationMisha HaninCEOmisha.hanin@31c.ioSOURCE: 31 Concept Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
全球首艘甲醇雙燃料動力滾裝船 “港榮”輪首航香港 ACN Newswire

全球首艘甲醇雙燃料動力滾裝船 “港榮”輪首航香港

香港,2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 9月28日,全球首艘9300CEU(標準車位)甲醇雙燃料動力滾裝船"CM HONG KONG"輪(中文名"港榮"輪)首航香港儀式在香港青衣舉行。全國政協副主席梁振英、香港特區政府政務司司長陳國基、中央政府駐港聯絡辦副主任祁斌、招商局集團董事長繆建民等出席,招商局集團副總經理鄧仁傑主持。梁振英在致辭時表示,"CM HONG KONG"輪是高新科技與香港航運發展的深度融合,標誌香港國際航運中心地位的提升,寄託了對香港繁榮穩定的美好願景。招商局集團作為香港歷史悠久的中資企業,始終與國家發展大局同頻共振,推動香港經濟社會繁榮發展。希望招商局集團持續創新,為香港和國家長遠發展貢獻力量。陳國基表示,招商局集團一直積極配合特區政府政策,走在綠色轉型的前線。"港榮"輪使用可以減少七成以上溫室氣體排放的綠色燃料,充分體現科技創新和環保理念的深度融合。期盼招商局集團繼續深耕香港、貢獻香港發展,在建設國際金融、航運、貿易三中心,以及國際高端人才集聚高地方面,發揮更大作用。繆建民表示,招商局集團與香港共榮共生,積極助力香港航運業高品質發展。"CM HONG KONG"輪冠以香港之名,承載繁榮祝願,更是招商局集團紮根香港的生動注腳。未來,招商局集團將加快綠色船舶建設,持續提升世界航商大會平台影響力,推動港航物流綠色化,助力香港打造全球航運業綠色低碳發展新樣本。儀式上,香港海事處處長王世發向"CM HONG KONG"輪船長頒發紀念牌。嘉賓們隨後登船參觀駕駛台、生活區及甲醇雙燃料動力系統,體驗該輪在低碳技術與裝載效率上的突破。有關機構嘉賓、招商局集團有關部門和二級公司負責人參加活動。"CM HONG KONG"輪由招商輪船訂造,是全球首艘採用甲醇雙燃料動力系統的大型汽車滾裝船。動力系統支援燃油與甲醇靈活切換,滿足國際海事組織Tier Ⅲ排放標準,使用綠色甲醇時可減排超70%。該船總長219.9米,型寬37.7米,設計裝載容量9300個標準車位元,實際可達9492個。總裝車面積78416平方米,約相當於11個標準足球場。配備13層裝載甲板,其中3層為可調節升降甲板,另有3層專為氫燃料電池車設計。尾跳與側跳雙裝卸通道提升裝卸效率30%。全船配備156個閉路電視監控系統,13層甲板均設耦合熱成像紅外探頭,確保安全。"CM HONG KONG"輪首航執行中國至歐洲航線,在香港卸車後將駛往歐洲。招商輪船將充分利用香港自由港的獨特優勢,參與推動香港"綠色燃料貿易+港口服務"模式,助力打造新的經濟增長點,吸引更多國際船舶來港加注綠色燃料,為香港綠色航運樞紐的發展注入新動能。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
World’s First Methanol Dual-Fuel PCTC ‘CM HONG KONG’ makes its maiden voyage to Hong Kong ACN Newswire

World’s First Methanol Dual-Fuel PCTC ‘CM HONG KONG’ makes its maiden voyage to Hong Kong

HONG KONG, Sep 29, 2025 - 28 September, The world's first 9,300 CEU methanol dual-fuel Pure Car and Truck Carrier (PCTC), "CM HONG KONG", celebrated its maiden voyage with a ceremony in Tsing Yi, Hong Kong. Vice-chairperson of the National Committee of the Chinese People's Political Consultative Conference, Leung Chun-ying, Chief Secretary for Administration of the HKSAR, Chan Kwok-kei, Deputy Director of the Liaison Office of the Central People's Government in the HKSAR, Qi Bin, and Chairman of China Merchants Group Limited, Miao Jianmin, etc. attended the ceremony, with Executive Vice President of China Merchants Group Limited, Deng Renjie, as the master of ceremonies.During the event, a commemorative plaque was presented to the ship's captain. Guests toured the vessel's bridge, crew quarters, and innovative methanol dual-fuel system, witnessing its advancements in low-carbon technology and operational efficiency.Built for China Merchants Energy Shipping (CMES), "CM HONG KONG" is the first large-scale car carrier powered by a methanol dual-fuel system, enabling seamless switching between conventional fuel and methanol. Compliant with IMO Tier III emission standards, it achieves over 70% emissions reduction when using green methanol. The ship, measuring 219.9 meters long and 37.7 meters wide, has a design capacity of 9,300 CEUs, with an actual capacity of up to 9,492 CEUs. Its 78,416-square-meter loading area, equivalent to 11 football fields, features 13 decks, including three adjustable lift decks and three tailored for hydrogen fuel cell vehicles. Dual stern and side ramps boost loading/unloading efficiency by 30%. Safety is enhanced with 156 CCTV cameras and thermal imaging infrared sensors across all decks."CM HONG KONG" embarked on its inaugural China-to-Europe route, unloading vehicles in Hong Kong before heading to Europe. Leveraging Hong Kong's free port status, CMES aims to advance the "green fuel trade + port services" model, fostering economic growth, attracting international vessels for green fuel bunkering, and strengthening Hong Kong's role as a global green maritime hub.Vice-chairperson of the National Committee of the Chinese People's Political Consultative Conference, Leung Chun-ying, delivered a speech at the ceremony.Chief Secretary for Administration of the HKSAR, Chan Kwok-kei, delivered a speech at the ceremony.Chairman of China Merchants Group Limited, Miao Jianmin, delivered a speech at the ceremony. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
World Quantum Summit 2025 Concludes to a Full House: “Quantum Unboxed” Signals the Next Leap in AI and Industry Transformation ACN Newswire

World Quantum Summit 2025 Concludes to a Full House: “Quantum Unboxed” Signals the Next Leap in AI and Industry Transformation

SINGAPORE, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - The future arrived today in Singapore as the World Quantum Summit 2025 (WQS) — themed “Quantum Unboxed: Extending the Reach of AI” — concluded at the Sheraton Towers Singapore with a full house attendance filling the ballroom to capacity. The overwhelming turnoutunderscored the growing global appetite for practical quantum solutions that extend the power of artificial intelligence and accelerate its real-world impact.This year’s summit was not a standalone event but the culmination of a three-day intensive journey into the future of computing and intelligence. On 23–24 September, participants took part in a sold-out Executive Workshop on Quantum and AI, which built foundational understanding of quantum principles, emerging architectures, and integration strategies. The final day brought it all together, showcasing how those concepts are now being deployed in industry — from real-world applications to large-scale investment strategies.Unlike traditional conferences focused solely on research or theory, WQS 2025 brought together the entire ecosystem driving quantum innovation forward. The summit featured practitioners representing different quantum approaches, policy makers, venture investors, academics, corporates, researchers, and ecosystem partners — all converging under one roof to chart the path from lab breakthroughs to industry-scale adoption. On the exhibition floor, leading players such as ST Engineering, QBoson, and TM Research & Development showcased quantum - enhanced solutions in optimisation, secure computing, and AI acceleration. Meanwhile, Gold Capital Network Partners — IMGT and IWC Management — hosted curated sessions connecting founders and investors to accelerate funding into quantum ventures poised for growth.A key highlight was the line-up of 19 world-class speakers, each offering cutting-edge insights into how quantum is transforming the AI landscape. Among them were Assoc. Prof. Mile Gu, Deputy Director of the Nanyang Quantum Hub at Nanyang Technological University; Jeremy Woo, Senior Technical Advisor at D-Wave System; Deepak Waghmare, CTO (APJC) of Dell Technologies; Ujjwal Kumar, Principal Architect, Office of the CTO at Microsoft Asia; Dr. Simon See, Senior Director and Global Head of the NVIDIA AI Technology Center; Bruno Aznar Martinez, R&D Software Developer at Keysight Technologies; Raghunath Koduvayur, CEO of RAQS Quantum; Gao Qi, Algorithm Director at QBoson; Ken Chew, CEO and Partner of IWC Management; and Tony Gu, General Partner at NGC Ventures. They were joined by Ong Yongcheng of Insignia Ventures, Dr. Amelia Tan of ST Engineering, Eric Lee of Deloitte Southeast Asia, Atsushi Sugiura of Oxford Quantum Circuits, Hidetoshi Matsumura of Fujitsu Limited, Ray Han of SAP, Duleesha Kulasooriya of Deloitte, Manisha Sharma Kohli of Google, and Simon Lawrie of AWS.Throughout the summit, a clear narrative emerged: quantum computing has moved beyond theory into strategic deployment, offering a powerful multiplier for AI. Industry leaders showcased case studies where quantum-enhanced AI is already delivering breakthrough results — from accelerating molecular simulations and optimising financial portfolios to solving supply chainchallenges previously considered intractable. Discussions highlighted how enterprises are integrating quantum capabilities directly into their AI workflows, achieving dramatic improvements in processing power, speed, efficiency, and cost-to-insight.The summit also reflected the shifting investment landscape. As quantum technologies mature, institutional and venture capital investors are moving rapidly to back companies with commercially viable products and near-term revenue potential. “Quantum is no longer the future — it’s today’s most powerful strategic edge and already seeing some real applications,” said Ken Chew, CEO of IWC Management. “The confluence of quantum and AI and their cross-synergies are powerful and those who integrate it into their AI stack early will potentially define the competitive landscape of the next decade.”By the close of the event, one message was clear: quantum will not replace AI — it will supercharge it. With practitioners, investors, policymakers, and researchers now aligned on the urgency of adoption, the era of practical quantum applications is no longer a distant vision — it is here, and it is redefining howindustries think about computation, intelligence, and innovation.The World Quantum Summit has firmly established itself as Asia’s premier platform for quantum commercialisation, bridging science, industry, and capital to accelerate real-world adoption. With its unique focus on applications over abstraction and its ability to convene the full quantum ecosystem, WQS is not just a conference — it is a catalyst for the next wave of technological transformation.Media Contact:Eric KhooConference Director, TPGI Pte Ltderic.khoo@pinnaclegroup.global+65 8383 2480 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
華領醫藥宣佈中國香港衛生署藥物辦公室正式受理多格列艾汀新藥上市許可申請 ACN Newswire

華領醫藥宣佈中國香港衛生署藥物辦公室正式受理多格列艾汀新藥上市許可申請

香港衛生署受理多格列艾汀的新藥上市許可申請(NDA),多格列艾汀是全球首個獲批的葡萄糖激酶激活劑(GKA)基于中國大陸的上市批准,以及强大的III期臨床研究和真實世界臨床結果,多格列艾汀顯示出持久的血糖控制和安全性香港將成爲華領醫藥向東南亞及全球拓展的重要支點上海,2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 華領醫藥("公司",香港聯交所股份代號:2552)宣佈,中國香港特別行政區衛生署已正式受理多格列艾汀(dorzagliatin)的新藥上市許可申請(NDA)。多格列艾汀是世界上第一個獲批准用于治療2型糖尿病(T2D)的葡萄糖激酶激活劑(GKA)。此次NDA被受理是華領醫藥拓展中國大陸以外市場戰略的一個重要里程碑,有望將其創新的疾病療法帶給更多亞洲患者,幷最終推向全球市場。香港有超過50萬人患有糖尿病,亞洲有近2.4億人患有糖尿病,多格列艾汀的NDA是解决該地區最緊迫的健康挑戰之一的重要一步。一款具有全球潜力的首創療法多格列艾汀于2022年9月獲得中國國家藥品監督管理局(NMPA)的上市批准,獲批兩個適應症:1)單獨用藥治療未經藥物治療的2型糖尿病患者,可以用于一綫治療;2)在單獨使用鹽酸二甲雙胍血糖控制不佳時,與鹽酸二甲雙胍聯合使用,改善成人2型糖尿病患者的血糖控制。與傳統的降糖藥物不同,多格列艾汀通過修復人體的葡萄糖傳感器--葡萄糖激酶(GK)的功能,直擊血糖調節异常的根源。通過恢復葡萄糖敏感性,多格列艾汀有助于維持血糖平衡,幷支持疾病的長期管理。在中國開展的兩項III期注册臨床研究結果顯示,多格列艾汀能顯著且持續地降低糖化血紅蛋白(HbA1c)水平,改善胰島β細胞功能,降低胰島素抵抗,同時具有良好的安全性和耐受性。目前正在進行的真實世界研究進一步驗證了這些發現,其中部分中期分析結果和數據已在2025年美國糖尿病協會(ADA)科學年會上公佈。通往新市場的戰略門戶作爲地區的醫療和金融樞紐,香港地區在糖尿病社區管理中已形成了一套較爲完善且行之有效的體系。香港中文大學香港糖尿病及肥胖症研究所的研究成果顯示,推行社區爲本的公私營協作糖尿管理模式成效顯著。香港地區的先進經驗對提升糖尿病患者生活質量、控制病情發展及减輕醫療負擔具有重要意義,待多格列艾汀在香港獲批,也將爲産品的糖尿病個性化管理提供更豐富的臨床應用經驗。香港過去的新藥審批制度規定,申請人須向管理局提供由兩個或以上認可國家的藥物監管機關發出的新藥注册證明文件,以及其他規定的相關文件,才能支持該産品的審批上市。但在新設的"1+"機制下,在符合本地臨床數據支持等要求,幷經本地專家認可新藥的適用範圍後,只須提交一個(而非原來的兩個)參考藥物監管機構的許可,便可以在香港申請注册。該制度最早適用于治療嚴重或罕見疾病的新藥,2024年開始擴展至所有新藥。在集團運營和大灣區發展部副總裁曹蓓莉女士的領導下,華領醫藥積極與香港當地臨床專家和監管部門進行了充分且深入的溝通,成爲這一政策的早期探路者。華領醫藥在7月底順利完成多格列艾汀的新藥遞交申請,幷于9月底正式受理。華領醫藥創始人兼CEO陳力博士表示:"多格列艾汀在香港的NDA獲得受理,不僅是對多格列艾汀臨床價值的認可,也是華領醫藥國際化進程中的重要一步。香港是地區醫療領域的引領者和金融樞紐,其獨特的地位使其成爲將多格列艾汀的影響力拓展至東南亞及其他地區的理想門戶。我們會繼續與香港本地醫生及合作夥伴携手探索多格列艾汀在糖尿病前期、糖尿病早期治療和預防等方面的潜力,讓全球更多患者能從這一突破性療法中獲益。"多格列艾汀:一款變革性的2型糖尿病治療藥物多格列艾汀于2022年9月在中國大陸獲批,幷被納入2024年1月1日正式執行的國家醫保藥品目錄。多格列艾汀可作爲新診斷患者的一綫單藥治療藥物,也可在二甲雙胍單獨用藥血糖控制不佳時與二甲雙胍聯合使用,用于治療成人2型糖尿病。與許多其它已獲批的口服抗糖尿病藥物不同,腎功能不全患者使用該藥物無需調整劑量。其作用機制是修復人體的葡萄糖傳感器--葡萄糖激酶,恢復葡萄糖敏感性和長期血糖平衡。多格列艾汀可以作用于多個關鍵器官:刺激胰腺分泌胰島素、促進腸道分泌GLP-1、調節肝臟中的糖原。這種多靶點的作用方式可以直擊2型糖尿病的根源,而非僅僅緩解其症狀。此次在香港地區的NDA申請基于兩項在中國開展的多格列艾汀單藥以及聯合二甲雙胍治療 T2D 患者的 III 期注册臨床研究結果。兩項研究表明,針對新診斷未用藥和二甲雙胍足量治療失效的兩類2型糖尿病患者,通過修復GK的傳感器功能缺陷,多格列艾汀能够持續、有效降低患者的HbA1c水平,顯著降低餐後兩小時血糖值(PPG),在無低血糖條件下血糖達標率高,具有良好的安全性和耐受性,幷且能够持續改善β細胞功能和降低胰島素抵抗。前瞻性聲明本文包含有關華領醫藥以及産品未來預期、計劃和前景的陳述。該等前瞻性陳述僅與本文作出該陳述當日的事件或資料有關,可能因未來發展而出現變動。除法律規定外,于作出前瞻性陳述當日之後,無論是否出現新資料、未來事件或其他情况,我們幷無責任更新或公開修改任何前瞻性陳述及預料之外的事件。請仔細閱讀本文幷理解,由于各種風險、不確定性或其他法定要求我們的實際未來業績或表現可能與預期有重大差异。關于華領華領醫藥("本公司")是一家總部位于中國上海的創新藥物研發和商業化公司,在美國、中國香港設立了公司。華領醫藥專注于未被滿足的醫療需求,爲全球患者開發全新療法。華領醫藥匯聚全球醫藥行業高素質人才,融合全球創新技術,依托全球優勢資源,研究開發突破性的技術和産品,引領全球糖尿病醫療創新。公司核心産品華堂寧®(多格列艾汀片)以葡萄糖傳感器葡萄糖激酶爲靶點,提升2型糖尿病患者的葡萄糖敏感性,改善患者血糖穩態失調。2022年9月30日,華堂寧®已獲得中國國家藥品監督管理局(NMPA)的上市批准,用于單獨用藥或者與二甲雙胍聯合用藥,治療成人2型糖尿病。對于腎功能不全患者,無需調整劑量,是一款可用于腎功能損傷的2型糖尿病患者的口服降糖藥物。詳情垂詢華領醫藥網址:www.huamedicine.com投資者電郵:ir@huamedicine.com媒體電郵:pr@huamedicine.com Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin ACN Newswire

Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin

Hong Kong Department of Health accepts NDA for dorzagliatin, the world’s first approved glucokinase activator (GKA).Builds on China approval and strong Phase III and real-world clinical results showing durable glucose control and safety.Positions Hong Kong as a strategic gateway for Hua Medicine’s global expansion into Southeast Asia and beyond.SHANGHAI, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (“the Company”, HKEX: 2552) announced that the Department of Health of the Hong Kong Special Administrative Region of China accepted a New Drug Application (NDA) for dorzagliatin, the world’s first glucokinase activator (GKA) approved for the treatment of Type 2 diabetes (T2D).The acceptance of the NDA marks an important milestone in Hua Medicine’s strategy to expand beyond China, bringing its innovative, disease-modifying treatment to more patients across Asia and ultimately to global markets.With more than half a million people living with diabetes in Hong Kong and nearly 240 million across Asia, the NDA represents a significant step toward addressing one of the region’s most urgent health challenges.A first-in-class therapy with global potentialDorzagliatin was approved for marketing by the China National Medical Products Administration (NMPA) in September 2022 for two indications, both to improve blood glucose control for T2D patients, 1) It can be used as mono-treatment for drug-naïve T2D patients, as first-line treatment, 2) When metformin hydrochloride alone has poor blood glucose control, it can be used in combination with metformin hydrochloride. Unlike conventional drugs that manage symptoms, dorzagliatin targets the root cause of blood sugar dysregulation by repairing the function of glucokinase (GK), the body’s glucose sensor. By restoring glucose sensitivity, dorzagliatin helps maintain blood sugar balance and supports long-term disease management.Results from two Phase III registration trials in China demonstrated that dorzagliatin significantly and sustainably lowered HbA1c levels, improved pancreatic β-cell function, and reduced insulin resistance, all while showing strong safety and tolerability. Findings are being further validated in ongoing real-world studies, of which some interim analysis and data were presented at the 2025 American Diabetes Association (ADA) Scientific Sessions.Strategic gateway to new marketsHong Kong has established a comprehensive, community-based system for diabetes management and serves as a medical and financial hub for the region. Research findings from the Hong Kong Diabetes and Obesity Research Institute at The Chinese University of Hong Kong indicate that the implementation of a community-based public-private collaboration model for diabetes management provided significant benefits to the community. The advanced experience in Hong Kong is of great significance for improving the quality of life of diabetes patients, controlling the progression of the disease, and reducing the burden on the healthcare system. Once approved in Hong Kong, it will also provide clinical application of dorzagliation for the personalized management of diabetes.According to Hong Kong's former new drug approval mechanism, applicants were required to submit to the authority new drug registration certificates issued by the drug regulatory agencies of two or more recognized countries, as well as other specified relevant documents, in order to support the approval and marketing of the product. Under the newly established "1+" mechanism, after meeting requirements such as local clinical data support and having the applicable scope of the new drug endorsed by local experts, an applicant only needs to submit the approval from one (instead of the original two) reference drug regulatory authority to apply for registration of the new drug in Hong Kong. This mechanism initially applied to new drugs for the treatment of serious or rare diseases, and has been extended to all new drugs since 2024.Under the leadership of Ms. Beili Cao, Vice President of Department of Corporate Operation and Great Bay Development, Hua Medicine has conducted sufficient and in-depth communications with local clinical experts and regulatory authorities in Hong Kong, and became an early pioneer of this mechanism. The Company filed its application for registration of dorzagliatin in Hong Kong at the end of July, and the application was officially accepted by the end of September.Dr. Li Chen, Founder and Chief Executive Officer of Hua Medicine, said: “Acceptance of dorzagliatin’s NDA in Hong Kong is not only recognition of its clinical value but also a pivotal step in Hua Medicine’s international journey. Hong Kong’s unique position as a regional healthcare leader and financial hub makes it the ideal gateway for expanding dorzagliatin’s reach into Southeast Asia and beyond. We are committed to working with local doctors and partners in Hong Kong to explore dorzagliatin’s potential in both treatment and prevention of prediabetes and early-stage diabetes, ensuring more patients worldwide can benefit from this breakthrough therapy.”Dorzagliatin: A transformative T2D treatmentDorzagliatin was approved in September 2022 in China, and it was included in the country’s National Reimbursement Drug List (NRDL) as of January 1, 2024.Dorzagliatin can be used alone as a first-line therapy for newly diagnosed patients, or together with metformin when blood sugar control is inadequate. Unlike many other approved oral antidiabetes drugs, no dose adjustment is required for patients with kidney impairment. It works by repairing the body’s glucose sensor, glucokinase (GK), restoring glucose sensitivity and long-term blood sugar balance. It acts across key organs—stimulating insulin secretion in the pancreas, boosting GLP-1 secretion in the gut, and regulating glycogen in the liver. This multi-target approach addresses the root cause of Type 2 diabetes, not just its symptoms.The NDA application in Hong Kong is based on the results of two Phase III registration clinical studies conducted in China evaluating the use of dorzagliatin monotherapy and in combination with metformin for the treatment of patients with Type 2 diabetes. Two studies have shown that for two categories of T2D patients—those newly diagnosed and not yet on medication, and those who have failed to respond adequately to metformin therapy— dorzagliatin can sustainably and effectively lower patients' HbA1c levels by repairing defects in the glucose sensor function of GK, significantly reduce postprandial two-hour blood glucose levels (2h-PPG), achieve high glycemic control rates without hypoglycemia, demonstrate good safety and tolerability, and continuously improve β-cell function and reduce insulin resistance.Forward-Looking StatementsThis document contains statements regarding Hua Medicine’s future expectations, plans, and prospects for the Company and its products. These forward-looking statements pertain only to events or information as of the date they are made and may change due to future developments. Unless required by law, we are not obligated to update or publicly revise any forward-looking statements or unexpected events after the date of such statements, regardless of new information, future events, or other circumstances. Please read this document carefully and understand that our actual future performance or results may differ materially from expectations due to various risks, uncertainties, or other legal requirements.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsWebsite: ir@huamedicine.comMediaWebsite: pr@huamedicine.com Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
SIG x ARK超260億日圓助陣Quantum Solutions:開啟日本ETH儲備上市公司新時代 ACN Newswire

SIG x ARK超260億日圓助陣Quantum Solutions:開啟日本ETH儲備上市公司新時代

東京,2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 據Quantum Solutions Co.,Ltd.(東京證券交易所代碼:2338,下稱「Quantum Solutions」)於2025年9月26日發布的公告顯示,公司已啟動超260億日圓(約1.8億美元)的戰略融資計劃,首輪募集金額達221億日圓(約1.5億美元),公告列出三家國際機構資本參與。這一消息一經公布,隨即引發廣泛關注。觀察人士指出,對日本投資者而言,這是繼巴菲特入股五大商社後,多家美國機構資本對日本資本市場的又一次深度押注;對國際投資者而言,這則意味著日本市場正加速向全球創新資本開放,迎來全新價值重估機會。多家國際機構資本同台亮相,日本市場再獲國際加持本輪融資的投資者組合被部分市場人士稱為「國際資本夢幻陣容」。由Cathie Wood主導的ARK Invest首度將版圖拓展至亞洲,被市場視為其在美國之外的重要戰略突破。ARK長期以來以精準捕捉破壞式創新與新興科技趨勢聞名,市場人士認為,ARK的此次入局被解讀為對Quantum Solutions戰略定位的高度認可,也折射出國際創新資本對日本市場的積極態度。與此同時,全球最大量化交易與專業投資集團之一的SIG(Susquehanna International Group),據公開資料,透過旗下CVI Investments出手,其資本市場經驗與風控能力被認為可為Quantum Solutions後續的流動性管理與資本效率優化提供制度性支持。第三位參與者則是由任德章(TC Yam)先生領導的Integrated Asset Management(IAM)。IAM結合國際金融與媒體資源的跨界優勢,被部分觀察人士視為有助於Quantum Solutions增添資本實力,更進一步鞏固其在全球投資者社群中的聲譽與公信力。三家重量級機構的聯手進駐,無論從資金來源還是象徵意義上,被部分市場人士視為為Quantum Solutions及日本資本市場帶來強力背書。在融資架構上,本輪主要採用可轉換債券以及浮動與固定行權價認股權證,合計發行規模約4,400萬股,近似於現有股份的翻倍。市場分析認為,該融資架構顯示國際投資者對Quantum Solutions長期發展前景的信心,另一方面也為公司未來的戰略轉型提供了充足資本彈藥。市場分析人士指出,經過本次融資強化後,Quantum Solutions的資本結構更趨穩健,不僅具備更強的抗風險能力,亦為投資者帶來估值修復與長期增長的雙重空間。ETH Treasury首例登場,差異化戰略開啟新賽道此次融資落地後,Quantum Solutions將正式啟動其ETH Treasury戰略,以募集資金長期持有以太坊(ETH)。虽在公告内未提及具体运营计划,但市场预测,Quantum Solutions会在合規框架下透過Staking、智能合約與多元流動性策略實現資產增值與風險管理。至此,Quantum Solutions將成為日本首家实质性将ETH納入公司金庫(Treasury)的上市公司,開創本土市場的歷史先例。與眾多選擇比特幣(BTC)作為核心資產的公司不同,Quantum Solutions在戰略層面另闢蹊徑。ETH不僅是一種數位資產,更是整個區塊鏈應用層的基礎設施。其智能合約功能為去中心化金融(DeFi)、NFT、生態協議等提供支撐,使其具備更持續的增值潛力。美國市場的數據顯示,ETH Treasury的估值普遍高於BTC Treasury,市淨率溢價約為6.5倍,顯示投資者對ETH帶來的長期回報有更高期待。換言之,ETH Treasury的差異化邏輯在於「資產+應用」的雙重驅動,有分析認為,Quantum Solutions的策略恰恰抓住了這一先行者優勢。本輪融資完成後,预测其公司預計可逐步累積超過8萬枚ETH,並有望在短期內躋身全球領先的ETH Treasury公司之列。市場觀察認為,結合ARK、SIG與IAM的戰略協同,Quantum Solutions不僅能夠獲得資金與專業知識的輸入,還將在品牌、技術與合規治理方面持續受益。部這一戰略落地對日本市場而言,既是一次新資產類別的制度性突破,也將為本土上市公司在全球區塊鏈版圖中提供一個可供複製的成功範例。對於零售投資者來說,這意味著他們能夠首次通過傳統資本市場的管道,間接參與ETH相關收益,開啟全新的投資故事。日本政策紅利釋放,Quantum Solutions長期主義聚焦股東價值日本市場正在迎來新的轉折點。隨著政府在Web3政策上不斷釋放利好訊號,監管環境日漸清晰與友善,投資者正尋找新的參照標的。相比之下,美國已經出現了BitMine、BTCS等BTC/ETH Treasury公司,市值一路走高,成為資本市場的新焦點;而日本卻一直缺乏同類型的上市公司。分析人士認為,Quantum Solutions的進場,不僅填補了這個空白,更以「日本第一」的身份打開新的篇章。它的出現,等於在市場上立下一個新的定價參考,讓投資者有了一個全新故事可以跟隨,也為資金流入和市場活化創造了條件。值得注意的是,根據公開資訊,Quantum Solutions管理層多年來持續探索新賽道。他們曾經推動AI算力、雲端基礎設施和數位解決方案等業務轉型,每一步都在嘗試新的增長曲線。本輪超260億日圓的融資落地,更是一次關鍵轉折點。市場解讀認為,隨著ARK、SIG和IAM三大國際資本的聯手加持,公司不僅獲得資金支持,更得到國際市場的高度背書,釋放出「聚焦股東價值最大化」的明确信號。分析人士指出,投資者因此認為Quantum Solutions不僅有資本實力,還有國際資源與長期戰略,市場信心自然水漲船高。根據公開資訊,Quantum Solutions管理層一直在探索新賽道。从推動AI算力、雲端基礎設施和AIGC解決方案,每一步都在寻求新的增長曲線。本輪超260億日圓的融資落地,是一次關鍵轉折點。隨著ARK、SIG和IAM三大國際資本的聯手加持,公司不僅獲得了資金支持,更得到國際市場的背書,釋放出「聚焦股東價值最大化」的明确信號。關於 Quantum Solutions根據其官網與公開資訊,Quantum Solutions Co.,Ltd.(東京證券交易所:2338)是一家總部位於日本東京的高成長科技企業,專注於人工智能、大數據分析及區塊鏈相關技術的研發與應用。公司成立於2004年,並於東京證券交易所掛牌上市。更多信息請訪問公司官網:https://www.quantum-s.co.jp/en/corporate前瞻性聲明本新聞稿包含根據公司目前可取得之資訊,以及對未來事件與預期所作的若干假設所形成的前瞻性聲明。此類聲明涉及各種風險與不確定性,包括但不限於政策變動、市場狀況、技術發展及監管因素,皆可能導致實際結果與此類聲明中所表達或暗示的結果出現重大差異。建議現有及潛在投資者審慎評估潛在風險,並避免對本新聞稿中所包含的任何前瞻性聲明寄予過高信賴。此類聲明僅適用於本新聞稿發佈之日,除法律另有規定外,公司並無義務因新資訊、未來事件或其他情況而更新或修正任何前瞻性聲明。如有進一步查詢,請聯絡:香港/國際:Mr. Steven TungEmail: publicrelations@quantum-s.co.jp日本:Ms. Linda PengEmail: publicrelations@quantum-s.co.jp Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Quantum Solutions to Soar Past 100,000 ETH as Landmark Investment from SIG x ARK x IAM Crowns Japan’s ETH Champion ACN Newswire

Quantum Solutions to Soar Past 100,000 ETH as Landmark Investment from SIG x ARK x IAM Crowns Japan’s ETH Champion

TOKYO, Sep 29, 2025 - (ACN Newswire via SeaPRwire.com) – Quantum Solutions Co., Ltd. (Tokyo Stock Exchange Code: 2338.T, “Quantum”) announced its strategic financing initiative on September 26 to issue 44 million shares to a blue-chip investor mix of three heavyweight institutions, providing the necessary permanent capital and network access to position Quantum as a potential frontrunner in the world of Ethereum (ETH) listed strategies and a showcase standout in the Tokyo stock market.For Japanese investors, this represents another significant commitment by leading US capital, following Warren Buffett’s investment in Japan’s five major trading companies. For international investors, it signals that Tokyo’s stock market is an increasingly attractive destination for global capital, welcoming new opportunities for “smart money”.Dream Team of Global Capital Aligns for Quantum, International Demand for Japanese Equities Continues to GrowQuantum’s investor line-up is a market stunner in the emerging field of crypto-linked equities. Susquehanna International Group (SIG), investing via CVI Investments, holds the capital firepower to accelerate Quantum’s ETH accumulation and expand its balance sheet for upcoming fundraising rounds. With a portfolio that includes early investments in ByteDance and Strategy Inc. (NASDAQ: MSTR), SIG is a Tokyo Stock Exchange participant, offering the robust capital infrastructure that analysts consider essential for a successful Digital Asset Treasury (DAT).Cathie Wood affirms her position as the world’s leading investor in crypto-linked equities with ARK Invest’s first direct foray into APAC-listed opportunities. In the US market, ARK has a track record for identifying category leaders such as ETH Treasury Bitmine Immersion Technologies (NYSE: BMNR) and cryptocurrency exchange Coinbase (NASDAQ: COIN). By adding Quantum, Wood extends her expertise to the Tokyo market, bringing visibility to Quantum in front of the global investing audience as the region’s most promising ETH Treasury initiative.The third participant is Hong Kong-based Integrated Asset Management (IAM), led by Mr. TC Yam. As the majority shareholder of Forbes Media, IAM’s cross-sector presence in international finance and media resources bolsters Quantum’s capital depth and reputational standing. Like ARK, IAM makes its first public investment in the Tokyo stock market, signaling growing confidence among global institutional investors in Japan's equity market.The fundraise utilizes convertible bonds and both floating and fixed strike price warrants for a total issuance of approximately 44 million shares, nearly doubling the company’s existing share capital. None of the instruments are priced at a discount, a rarity for DAT fundraises, suggesting that the incoming investors are targeting long-term growth prospects. As of market closing on September 26, the nominal value of the financing round comes to over JPY 26 billion (approx. USD 180 million), with the first tranche valued at JPY 22.1 billion (approx. USD 150 million).First ETH Treasury in Japan — A Differentiated Strategy Offering Long-Term Returns on EquityAccording to research reports by leading investment banks, the key determinants of success for listed Digital Asset strategies are robust access to capital and a team with operational blockchain expertise. Through this fundraising initiative, Quantum taps into fresh sources of capital and aligns with investors of strong reputation, prompting market expectations of long-term backing.Quantum CEO Francis B. Zhou is no newcomer to the Digital Asset industry, as one of the first institutional investors and operators in the blockchain space. In 2018, Zhou acquired the world’s second largest ETH mining facility, based in Jokkmokk, Sweden. Zhou maintains investments in early stage blockchain projects alongside film and IP holdings in his venture investment portfolio, and brings a network of experienced blockchain operators, including Head of Crypto Strategy Donny Chi.Proceeds from Quantum’s financing initiative will be used to accumulate ETH. Although BTC has demonstrated adoption as a store-of-value, ETH is the foundational asset for blockchain applications, enabling companies like Quantum to explore attractive yield-generating opportunities to drive a blend of organic and inorganic growth for the company’s core treasury and balance sheet.The appeal of yield-bearing strategies is supported by data from the US market, which indicates that listed ETH Treasuries trade at a price-to-book multiple of 7.72x, more than 3 times higher than that of listed BTC Treasuries. More remarkably, the price-to-book of ETH Treasuries is trending upwards, increasing by over 20% within the trading month of September, demonstrating that the market expectations continue to strengthen for listed ETH Treasuries as it relates to long-term returns on equity.Zhou and the Quantum Solutions team have a history of exploring growth frontiers, consequently developing industry traction in AI computing, GPU hosting, and IP gaming. This positions the company to pursue unique opportunities beyond overcrowded sectors in Real World Asset (RWA) space to potentially generate more attractive returns.With the fundraise, Quantum’s notional price-to-book multiple is estimated to be less than 30% of the market median. Assuming that the company can reach its fair value, the structure of the fundraise allows the company to rapidly accelerate its capital accumulation to reach the target of 100,000 ETH within the near term, positioning Quantum among the leading ETH Treasury companies globally.Growth Driven Policies in Japan Encourage Prospects for Long-Term Shareholder ValueConsistent government support for the blockchain industry and increasing clarity in regulations are ushering in a more investor-friendly market for Digital Assets in Japan. Whereas the US market already has ETH Treasury companies such as Bitmine (NASDAQ: BMNR) and SharpLink Gaming (NASDAQ: SBET) achieving significant market cap growth as capital market highlights, Japan lacks a similar listed benchmark. Quantum Solutions’ entry fills this gap, opening a new chapter as "Japan’s first”, and creating conditions for capital inflow and renewed market participation.This financing round, nominally valued at approximately USD 180 million, is a landmark in both the Japanese stock market as well as the crypto-linked equities space. Through the combined endorsement of SIG, ARK, and IAM, Quantum not only secures funding but also international validation under a capital structure optimized to maximize long-term shareholder value. High-profile deals of this caliber further Tokyo as an emerging destination for savvy investors. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Mooreast 與中國國有基礎設施開發領導企業——中交集團機電工程局簽署戰略合作協議 ACN Newswire

Mooreast 與中國國有基礎設施開發領導企業——中交集團機電工程局簽署戰略合作協議

TAIPEI, TAIWAN, 2025年9月29日 - (亞太商訊 via SeaPRwire.com) - 新加坡 —— 新交所凱利板上市公司 Mooreast Holdings Ltd.(以下簡稱「Mooreast」或「集團」)今日表示,已與中國交通建設股份有限公司(「中交股份」)旗下子公司簽署《戰略合作協議》(「SCA」)。中交股份是中國國有的全球基礎設施開發領導企業。根據該協議,Mooreast 與中交機電工程有限公司(「中交機電」)計劃合作,在中國及全球其他地區共同開發浮式海上再生能源及相關近海與海洋工程專案的商機。該戰略合作將充分發揮中交機電在中國境內的規模化營運、專業技術、資源、聲譽與網絡優勢,同時結合Mooreast 在綠色低碳發展與浮式再生能源領域(包括海上風電)的技術能力、成功經驗與國際網絡。雙方亦將探索建立海上風電相關產業供應鏈的合作機會,提供涵蓋工程、採購、施工與安裝(EPCI)的綜合解決方案。Mooreast 與中交機電計劃推進涉及浮式風能及其他近海與海洋工程專案的合作,範圍包括工程設計、生產、分裝、運輸及/或系泊與索具系統、風力發電機、浮式平台及相關零部件或設備的安裝等。儘管這些產品與解決方案的主要市場在中國本土,但鑑於亞洲地區技術水平日益提升且生產成本持續下降,雙方亦看好海外市場的成長機遇。作為近海與海洋領域系泊與索具系統的專業公司,Mooreast 是亞洲唯一一家超高功率錨具設計與製造商。隨著全球浮式風電專案的商業化步伐加快,公司正積極擴展其在歐洲和東北亞的市場布局。Mooreast 執行董事兼副主席沈君南先生表示:「我們非常高興並榮幸能與中交機電這樣享有盛譽的企業建立合作。與陸上風電相比,中國的浮式海上風電產業仍有巨大潛力尚待開發。我們期待在不久的將來深化合作,把握國內外市場機遇。」本新聞稿已由公司贊助商大華繼顯私人有限公司(「贊助商」)審閱。本新聞稿尚未經新加坡交易所有限公司(「SGX-ST」)檢驗或批准,SGX-ST 對本新聞稿的內容不承擔任何責任,包括其中所載之陳述、意見或報告的正確性。贊助商聯絡人為大華繼顯私人有限公司高級副總裁 Lance Tan先生,地址:83 Clemenceau Avenue, #10-01 UE Square, Singapore 239920,電話:(65) 6590 6881。本新聞稿由 WeR1 Consultants Pte Ltd 代表 Mooreast Holdings Ltd. 發佈。關於 Mooreast Holdings Ltd.作為全面系泊解決方案的領導者,Mooreast 為近海石油與天然氣、航運及海上再生能源產業提供系泊系統的設計、工程、製造、供應與物流、安裝及調試等服務。憑藉近三十年的經驗,Mooreast 正將其在系泊解決方案領域的實績與專業能力應用於浮式再生能源專案,特別是浮式海上風電。公司已成功參與日本與歐洲的浮式海上風力發電機開發與原型專案。更多資訊,請瀏覽 https://mooreast.com/媒體與投資者聯絡方式WeR1 Consultants Pte LtdIsaac Tang, mooreast@wer1.net(手機:+65 9748 0688) Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Serving the Belt and Road, Setting a New Benchmark for Education, Tianli International School Breaks Ground in Laos National Administrative Center ACN Newswire

Serving the Belt and Road, Setting a New Benchmark for Education, Tianli International School Breaks Ground in Laos National Administrative Center

HONG KONG, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - Tianli International Holdings Limited (“Tianli International”) and Shenzhen Yidatong Group recently held a formal signing ceremony in Hong Kong to launch their strategic partnership. The agreement, signed at 3:00 PM on September 25th, marks the official start of a high-end international school project in the heart of Laos’s National Administrative Center.This collaboration represents far more than a commercial alliance. It is a key milestone in Tianli International’s dual strategic priorities—“Education AI” and “China International Education Going Global”—and a concrete step in response to China’s Belt and Road Education Initiative and the national blueprint China Education Modernization 2035, which calls for “a new era of educational openness.”Under the agreement, the partners will jointly develop a world-class international education complex featuring two flagship schools:Premier British Boarding School, offering a complete UK curriculum and authentic boarding traditions to nurture the next generation of global leaders from Laos and neighboring countries.Lida Chinese International School, centered on China’s national curriculum, this school will provide both general and academic Chinese tracks, establish a direct pathway to China’s top universities, and promote two-way student exchange programs.The signing ceremony drew congratulations from the China Association for Non-Government Education, which praised the project as a pioneering example of Chinese private education expanding abroad. Guests and witnesses attended from China, Laos, France, Malaysia, Gambia, and other countries.Dr. Luo Shi, Chairman and President of Tianli International, stated that the partnership is both a pivotal milestone in the group’s global strategy and a major advance in its “Education AI + China International Education Going Global” initiative. Looking ahead, the two partners plan to explore innovations in smart-campus infrastructure and AI-driven teaching, delivering high-quality, diversified education options to Southeast Asia and the wider world.Media ContactCompany: Tianli Education (HK ) LimitedContact Person: Dr. Brown FengZhaoEmail: zhaofeng@tianlieducation.com Website: https://www.tianlieducation.com/en/about/index.html Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More